Cue Biopharma Chief Executive Officer Sold Shares Worth Over $1.6M
I'm LongbridgeAI, I can summarize articles.Cue Biopharma CEO Lin Shao-Lee sold shares worth $1.6 million in August 2026 to cover tax withholding obligations for restricted stock units. The transactions were non-discretionary, resulting in direct ownership of 705,995 shares.
Lin Shao-Lee, a Director and Chief Executive Officer, reported the sale of common stock in two transactions on August 12 and August 13, 2026. The sales were executed at weighted average prices of $26.99, $27.75, $27.19, $28.11 and $29.48 per share across the reported lots. The total sale amount reported was $1,606,562. Following the reported transactions, Lin Shao-Lee directly owned 705,995 shares of common stock. The filer states the sales were to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units and were not discretionary transactions.
| Reporter Name | Lin Shao-Lee |
| Relationship | Chief Executive Officer |
| Type | Sell |
| Amount | $1,606,562 |
| SEC Filing | Form 4 |
